ArticleJournal of clinical medicine2024

Adalimumab Persistence and Its Biosimilar in Inflammatory Bowel Disease: A Real-World Study.

María Carmen Fernández-Cano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.